Newcastle disease virus exerts oncolysis by both intrinsic and extrinsic caspase-dependent pathways of cell death

Tumor selective replication of Newcastle disease virus: association with defects of tumor cells in antiviral defence

A phase 1 clinical study of intravenous administration of PV701, an oncolytic virus, using two-step desensitization

Combined action of virus injection and local tumor irradiation on tumor growth in mice

A tumor vaccine containing anti-CD3 and anti-CD28 bispecific antibodies triggers strong and durable antitumor activity in human lymphocytes

Virus-based therapies for colon cancer

Phase I/II trial of intravenous NDV-HUJ oncolytic virus in recurrent glioblastoma multiforme

Tumor-targeted gene transfer in vivo via recombinant Newcastle disease virus modified by a bispecific fusion protein

[Study of Newcastle disease virus killing hepatocellular carcinoma cells in vitro]

[Induction of apoptosis in human hepatoma cell line SMMC7721 by Newcastle disease virus HN gene]